VAS101, a Novel Curcumin Transdermal Formulation, Reverses Some Clinical Hallmarks of Aging
SUMMIT, N.J., March 17, 2025 /PRNewswire/ -- In a new study published in the journal GeroScience, VAS101 (Vasceptor®), a novel...
Neuroscience
Clario announces acquisition of imaging provider NeuroRx
Acquisition further builds on Clario's neuroscience expertise and capabilities PHILADELPHIA, March 17, 2025 /PRNewswire/ -- Clario, a leading provider of...
InTandem Capital Partners Announces Strategic Investment in Clinilabs
NEW YORK--(BUSINESS WIRE)--InTandem Capital Partners (“InTandem Capital” or the “Firm”), a healthcare services-focused private equity firm, announced today that it...
Clene Demonstrates Strengthened ALS Survival Benefit with CNM-Au8® Treatment
New Cross-Regimen Analysis of HEALEY ALS Platform Trial Shows Significant Survival AdvantageSALT LAKE CITY, March 12, 2025 (GLOBE NEWSWIRE) --...
Angelini Ventures leads €10 million Series A financing in Vantis, a Digital Care Innovation company
Strategic investment in digital health solutions addressing critical challenges in primary care and chronic disease management Rome, Italy, 12 March...
Ipsen appoints Olivia Brown as Executive Vice-President, Global Head of Neurotoxins
PARIS, FRANCE, March 12th, 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care-driven company, announced today the appointment...
openRxiv Launch to Sustain and Expand Preprint Sharing in Life and Health Sciences
DAVIS, Calif., March 11, 2025 /PRNewswire/ -- openRxiv has officially launched as an independent nonprofit to oversee bioRxiv and medRxiv,...
BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
Achieved record quarterly sales of $11.4 million in Q4 2024, an increase of 27% compared with Q4 2023 Full year...
ProMIS Neurosciences to Participate in the 37th Annual Roth Conference
CAMBRIDGE, Massachusetts, March 11, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the...
BioXcel Therapeutics Strengthens Cash Position to Advance SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
Topline data expected in second half of 2025 to support potential sNDA submission for label expansion of IGALMI® in the home...
Clario Enters into Definitive Agreement to Acquire WCG’s eCOA Business
Acquisition of WCG's electronic clinical outcome assessments (eCOA) business will expand Clario's scientific expertise and offerings in neuroscience PHILADELPHIA, March 10,...
DR. DEEPAK CHOPRA WITH CYBERHUMAN.AI AND ELEMIND ANNOUNCE PARTNERSHIP TO REVOLUTIONIZE SLEEP
Introducing "21 Days of Restful Sleep with Dr. Deepak Chopra & Elemind"—A New Ritual Combining Guided Meditations and Pioneering Wearable...
CYBERHUMAN.AI AND ELEMIND TECHNOLOGIES ANNOUNCE PARTNERSHIP TO REVOLUTIONIZE SLEEP
Introducing "21 Days of Restful Sleep with Dr. Deepak Chopra & Elemind"—A New Ritual Combining Guided Meditations and Pioneering Wearable...
MedRhythms Announces FDA Class II Listing for Movive™ to Support Gait Rehabilitation and Motor Function for Parkinson’s Disease
PORTLAND, Maine, March 6, 2025 /PRNewswire/ -- MedRhythms today announced that MR-005, the company's neurorehabilitation system to support gait rehabilitation...
Hemostemix and FireFly Neuroscience’s Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
A growing body of clinical evidence supports the use of Firefly's FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment...
Nationally-Recognized Health Care Providers, Leading Academics and State Leaders Address Access to Cancer Treatment in Florida’s Rural Communities
Tampa General Hospital Cancer Institute hosted a day of keynotes, presentations and discussions at TGH Brooksville to address the challenges...
Linus Health Achieves Landmark Research Recognition Across Peer-Reviewed Medical and Scientific Journals
Research validates the efficacy and accuracy of its digital solutions designed to detect early indicators of cognitive impairment BOSTON, March...
Care Solace Receives Strategic Growth Investment from Lemnis to Expand Mental Health Solutions
CARDIFF, Calif., March 4, 2025 /PRNewswire/ -- Care Solace, the leading provider of mental health care coordination services for K-12...
AI in Remote Patient Monitoring (RPM) Market worth $8,438.5 million by 2030 with 27.5% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., March 4, 2025 /PRNewswire/ -- The global AI in Remote Patient Monitoring Market, valued at US$1551.8 million...
Oberkotter Foundation Announces the Scientific Council for Childhood Hearing
Council will bring together global experts to deepen understandings about childhood hearing loss. PHILADELPHIA, March 3, 2025 /PRNewswire/ -- The...